DE2506260A1 - Verfahren zum entfernen pyrogenen materials aus waessrigen loesungen - Google Patents

Verfahren zum entfernen pyrogenen materials aus waessrigen loesungen

Info

Publication number
DE2506260A1
DE2506260A1 DE19752506260 DE2506260A DE2506260A1 DE 2506260 A1 DE2506260 A1 DE 2506260A1 DE 19752506260 DE19752506260 DE 19752506260 DE 2506260 A DE2506260 A DE 2506260A DE 2506260 A1 DE2506260 A1 DE 2506260A1
Authority
DE
Germany
Prior art keywords
asparaginase
solution
column
buffer solution
ionic strength
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19752506260
Other languages
German (de)
English (en)
Inventor
Roy Walter Grabner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2506260A1 publication Critical patent/DE2506260A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
DE19752506260 1974-02-15 1975-02-14 Verfahren zum entfernen pyrogenen materials aus waessrigen loesungen Withdrawn DE2506260A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US443063A US3897309A (en) 1974-02-15 1974-02-15 Process for removing pyrogenic material from aqueous solutions

Publications (1)

Publication Number Publication Date
DE2506260A1 true DE2506260A1 (de) 1975-08-21

Family

ID=23759282

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752506260 Withdrawn DE2506260A1 (de) 1974-02-15 1975-02-14 Verfahren zum entfernen pyrogenen materials aus waessrigen loesungen

Country Status (7)

Country Link
US (1) US3897309A (cg-RX-API-DMAC7.html)
JP (1) JPS5919088B2 (cg-RX-API-DMAC7.html)
CH (1) CH610760A5 (cg-RX-API-DMAC7.html)
DE (1) DE2506260A1 (cg-RX-API-DMAC7.html)
FR (1) FR2261048B1 (cg-RX-API-DMAC7.html)
GB (1) GB1479851A (cg-RX-API-DMAC7.html)
NL (1) NL7500983A (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907930C1 (cg-RX-API-DMAC7.html) * 1989-03-11 1990-06-13 Hans-Peter Dr. 6464 Linsengericht De Kabus

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3957582A (en) * 1974-11-20 1976-05-18 Abbott Laboratories Purification of urokinase
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4677194A (en) * 1985-08-09 1987-06-30 Biotech Research Laboratories, Inc. Isolation of an endotoxin inactivator from human plasma
US4705686A (en) * 1986-05-09 1987-11-10 American Cyanamid Process for the preparation of acellular Bordetalla pertussis vaccine
IT1222427B (it) * 1987-07-31 1990-09-05 Sclavo Spa Procedimento per la purificazione di interferone
US5578455A (en) * 1993-03-19 1996-11-26 Tanabe Seiyaku Co., Ltd. Method for determining endotoxin and apparatus therefor
US6194562B1 (en) 1998-04-22 2001-02-27 Promega Corporation Endotoxin reduction in nucleic acid purification
US7078224B1 (en) * 1999-05-14 2006-07-18 Promega Corporation Cell concentration and lysate clearance using paramagnetic particles
WO2002083710A2 (en) * 2001-04-13 2002-10-24 Wyeth Holdings Corporation Removal of bacterial endotoxin in a protein solution by immobilized metal affinity chromatography
CA2613094A1 (en) * 2005-07-01 2007-01-11 Promega Corporation Network of buoyant particles for biomolecule purification
WO2007070381A2 (en) * 2005-12-09 2007-06-21 Promega Corporation Nucleic acid purification with a binding matrix
US8222397B2 (en) * 2009-08-28 2012-07-17 Promega Corporation Methods of optimal purification of nucleic acids and kit for use in performing such methods
US8039613B2 (en) 2009-08-28 2011-10-18 Promega Corporation Methods of purifying a nucleic acid and formulation and kit for use in performing such methods
WO2020051642A1 (en) 2018-09-12 2020-03-19 Gelion Technologies Pty Ltd Battery with halogen sequestering agent

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634196A (en) * 1968-05-06 1972-01-11 Bayer Ag Process for the separation of pyrogens from crude preparations of l-asparaginase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2997425A (en) * 1959-05-05 1961-08-22 Ortho Pharma Corp Method of purification of streptokinase

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3634196A (en) * 1968-05-06 1972-01-11 Bayer Ag Process for the separation of pyrogens from crude preparations of l-asparaginase

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Römpp: Chemie-Lexikon, 7. Aufl., 1973, S. 1620 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3907930C1 (cg-RX-API-DMAC7.html) * 1989-03-11 1990-06-13 Hans-Peter Dr. 6464 Linsengericht De Kabus

Also Published As

Publication number Publication date
CH610760A5 (cg-RX-API-DMAC7.html) 1979-05-15
US3897309A (en) 1975-07-29
GB1479851A (en) 1977-07-13
JPS5919088B2 (ja) 1984-05-02
JPS50116681A (cg-RX-API-DMAC7.html) 1975-09-12
FR2261048B1 (cg-RX-API-DMAC7.html) 1980-06-20
FR2261048A1 (cg-RX-API-DMAC7.html) 1975-09-12
NL7500983A (nl) 1975-08-19

Similar Documents

Publication Publication Date Title
DE2506260A1 (de) Verfahren zum entfernen pyrogenen materials aus waessrigen loesungen
CH644520A5 (de) Verfahren zur herstellung eines die proliferation und differenzierung menschlicher granulopoetischer stammzellen stimulierenden faktors.
DE2944792C2 (cg-RX-API-DMAC7.html)
DE69124235T3 (de) Reinigung und verwendung von pertactin, eines bordetella pertussis aussenmembranproteins
DE3039566A1 (de) Verfahren zur reinigung von interferon
DE2752694A1 (de) Verfahren zur gewinnung von immunglobulin zur intravenoesen verabreichung
DE2059165A1 (de) Streptokinase in chemischer Bindung an eine Kohlehydratverbindung
DE1792600A1 (de) Impfstoff und Verfahren zur Herstellung
DE2519382A1 (de) Verfahren zur gewinnung einer gereinigten alpha-galactosidase aus einer alpha-galactosidase enthaltenden fluessigkeit
DE69511392T2 (de) Verfahren zur trennung von protektiven verbindungen aus bordetella pertussis
CH628088A5 (en) Process for obtaining streptococcal metabolic products
DE1617805B2 (de) Verfahren zur Gewinnung von Lysozym aus Eiweiß
DE2428955C3 (de) Verfahren zur Abtrennung der enzymatischen Komponente mit in vivo antikoagulierender und in vitro koagulierender Wirkung aus dem Gift der Schlange Ancistrodon rhodostoma und daraus hergestellte Mittel
DE2605576C3 (de) Verfahren zum Isolieren der Proteasen Papain,,Chimopapain, Lysozym und Proteinase X aus dem Milchsaft von Carica papya und Verwendung der isolierten Proteasen zur Herstellung von sterilisierten und Iyophilisirten orthopädischen, neurochirurgischen oder ophthalmologischen Präparaten
DE1940130C2 (de) Verfahren zur Reinigung von Insulin, nach diesem Verfahren gereinigtes Insulin und dessen Verwendung
DE2016269B2 (de) Verfahren zur Verlängerung der Lebensfähigkeit von Lymphocyten, die vom Blut abgetrennt worden sind
DE2748520C2 (cg-RX-API-DMAC7.html)
DE1695308C3 (de) Verfahren zur Isolierung von Adenosintriphosphat
DE1767404C3 (de) Verfahren zur Gewinnung von Lysozym aus einem lysozymhaHigen Ausgangsmaterial
DE1942900C3 (de) Verfahren zur Abtrennung von L-Asparaginase aus Bakterienkulturen, danach hergestellte L-Asparaginase und diese enthaltendes therapeutisches Mittel
DE2154557C3 (de) Verfahren zur Herstellung von hochreiner Kallidinogenase (Kallikrein) und ein die danach erhaltene kristalline Kallidinogenase enthaltendes Arzneimittel
DE1617279A1 (de) Verfahren zur Herstellung pharmazeutischer Praeparate zur Verhinderung der Bildung von Blutgerinnseln
DE2424118A1 (de) Verfahren zur herstellung von hochreinem kallikrein
DE1492243B2 (de) Injizierbare Impfstoffe
DE951228C (de) Verfahren zur Stabilisierung eines adrenocorticotropen Praeparates

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: ABITZ, W., DIPL.-ING.DR.-ING. MORF, D., DR., PAT.-

8139 Disposal/non-payment of the annual fee